Articles by Jill Wechsler - Pharmaceutical Executive


Articles by Jill Wechsler

FDA Gets a New Look

Dec 1, 2011

Agency expansion and globalization promote innovation, collaboration, and organizational changes

The Drug Shortages Struggle

Nov 1, 2011

Clamor for critical therapies prompts probes of prices, production practices.

Sidney Wolfe: Pharma's Unlikely Best Friend

Oct 1, 2011

Sidney Wolfe, MD, Director, Public Citizen's Health Research Group

Francis Collins: Guiding a Revolution in Science

Oct 1, 2011

Francis Collins, MD, PhD, Director, National Institutes of Health

Henry Waxman: "Representing" Healthcare to the Fullest

Oct 1, 2011

Henry Waxman, Congressional Representative from Los Angeles, California

Janet Woodcock: At the Helm of Industry

Oct 1, 2011

Janet Woodcock, MD, Director, FDA Center for Drug Evaluation and Research

Marck McLellan: An 'A' for Advancing Expectations

Oct 1, 2011

Marck McClellan, MD, Director, Engelberg Center for Health Reform, Brookings Institute

Rebates and Reform

Sep 1, 2011

User-fee renewal legislation sets the stage for new policies affecting reimbursement, research, and regulatory oversight.

The Supremes Shape Pharma

Aug 1, 2011

A number of important decisions from the Supreme Court will affect drug marketing, research, and regulation


Click here